Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapy.
Merle V, Marini H, Di Fiore F, Lottin M, Gray C, Loeb A, Fred A, Contentin N, Muir JF, Thiberville L, Pfister C, Huet E, Peillon C, Michel P, Czernichow P.
Merle V, et al. Among authors: czernichow p.
Support Care Cancer. 2016 Apr;24(4):1857-63. doi: 10.1007/s00520-015-2969-1. Epub 2015 Oct 10.
Support Care Cancer. 2016.
PMID: 26454864